FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and sanitation, specifically to a remedy for nucleic acid destruction containing ethidium monazide as the active component. The nucleic acid destroying remedy containing the monazide which destroys nucleic acid at exposure to light irradiation within visible spectre, as the active component. Antibacterial remedy containing the nucleic acid destroying remedy based on ethidium monazide. Method for destroying nucleic acid including stages of ethidium monazide being added to a nucleic acid sample, and of exposure of the nucleic acid sample to light irradiation within the visible spectre. Method for destroying nucleic acid inside the cell including stages of ethidium monazide being added to a sample containing the cell, and of exposure of the sample containing the cell to light irradiation within the visible spectre.
EFFECT: remedy based on ethidium monazide is beneficial as an antibacterial remedy, such as bactericidal or disinfecting remedy.
4 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND KIT FOR DETECTION OF MICROORGANISMS | 2010 |
|
RU2527897C2 |
| METHOD AND SET FOR MICROORGANISM DETECTION | 2008 |
|
RU2410440C1 |
| MICROORGANISM DETECTION METHOD AND MICROORGANISM DETECTION SET | 2006 |
|
RU2395583C2 |
| METHOD FOR SAMPLING FOR DETECTING MICROORGANISM, METHOD FOR DETECTING MICROORGANISM AND SET FOR DETECTING MICROORGANISM | 2006 |
|
RU2384624C2 |
| COMPLEXES OF NUCLEIC ACIDS | 2011 |
|
RU2568829C2 |
| DETERMINATION OF RATIO OF NUCLEIC ACIDS | 2018 |
|
RU2803339C2 |
| NUCLEIC ACIDS ISOLATION | 2013 |
|
RU2617947C2 |
| METHOD OF NUCLEIC ACID TRANSFER IN ANIMAL CELLS | 1990 |
|
RU2098487C1 |
| AGENT FOR TRANSFERRING NUCLEIC ACIDS OR THEIR DERIVATIVES IN HUMAN CELLS | 1992 |
|
RU2113485C1 |
| DELIVERY OF NUCLEIC ACIDS | 1995 |
|
RU2160278C2 |
